Add BrightSurf on Google Email

Institut Pasteur


Development of serological assays to detect SARS-CoV-2 antibodies

Scientists developed four serological assays to detect SARS-CoV-2 antibodies and two for neutralizing antibodies, showing that antibody responses appear 5-6 days after symptoms, with neutralizing activity after 7-14 days. The assays were highly sensitive and specific, with varying levels of availability depending on equipment.

SourceInstitut Pasteur·JournalScience Translational Medicine·DateAug 20, 2020

Cancer: The immune system attacks tumors remotely

Researchers at Institut Pasteur found that immune cells can attack cancer cells remotely through soluble molecules like interferon-gamma. This discovery supports a key target for future immunotherapy approaches and may enable T lymphocytes to act on a large number of cancer cells.

SourceInstitut Pasteur·JournalNature Cancer·DateMar 12, 2020

Identification of a key protein linked to ageing

Scientists from Institut Pasteur have identified a key protein associated with ageing, which is progressively depleted in cells leading to senescence. The discovery sheds light on the mechanisms of senescence and its link to cellular ageing, paving the way for potential therapeutic targets.

SourceInstitut Pasteur·JournalNature Communications·DateDec 9, 2019

Lassa fever: Vaccine set to be trialed

A vaccine for Lassa fever, a hemorrhagic disease causing up to 6,000 deaths annually, is set to enter human clinical trials. The measles platform-based vaccine demonstrated the best protection against the virus in preclinical tests.

SourceInstitut Pasteur·JournalScience Translational Medicine·DateOct 24, 2019

HIV: Reprogramming cells to control infection

Researchers at the Institut Pasteur successfully reprogrammed immune cells from individuals who naturally control HIV infection, granting them enhanced antiviral potency. This breakthrough could lead to novel treatments and potential cure options for those living with HIV, as previously described in a study published in Nature Metabolism.

SourceInstitut Pasteur·JournalNature Metabolism·DateJul 12, 2019

Zika: Silent long-term circulation in Thailand

Scientists discover Zika virus has been circulating in Thailand since at least 2002, defying South American pattern of viral strain similarity. The finding highlights the need for effective long-term surveillance systems to monitor the virus's activity.

SourceInstitut Pasteur·JournalThe Lancet Infectious Diseases·DateFeb 28, 2019

Gene therapy durably reverses congenital deafness in mice

Scientists have successfully restored auditory synapse function and hearing thresholds to a near-normal level in adult mice with DFNB9 deafness. The breakthrough uses an AAV-based gene therapy approach that can be used to produce otoferlin and durably correct the profound deafness phenotype in mice.

SourceInstitut Pasteur·JournalProceedings of the National Academy of Sciences·DateFeb 19, 2019

AIDS -- an approach for targeting HIV reservoirs

Researchers at Institut Pasteur have identified CD4 T lymphocytes as a key target for HIV infection and developed a new approach to eliminate infected cells. By blocking the virus's energy production, scientists can destroy infected reservoirs, potentially leading to remission.

SourceInstitut Pasteur·JournalCell Metabolism·DateDec 20, 2018

Yellow fever: A new method for testing vaccine safety

Scientists from Institut Pasteur and partners have developed a cellular test to verify the safety of live vaccines like yellow fever vaccine. The 3D culture model, BBB-Minibrain, detects rare mutant particles with neuroinvasive properties, paving the way for reduced animal testing in quality control.

SourceInstitut Pasteur·JournalBiologicals·DateJun 14, 2018

A new Listeria species from Costa Rica identified

A new bacterial species, Listeria costaricensis, has been identified in Costa Rica, increasing the knowledge of Listeria's pathogenic potential. The discovery was made through a three-year research project that sampled water from an industrial drainage area, revealing the biodiversity of Costa Rican soils.

SourceInstitut Pasteur·JournalINTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY·DateApr 17, 2018

Hepatitis C: A novel point-of-care assay

A novel point-of-care Hepatitis C assay has been developed to diagnose chronic cases in asymptomatic patients, particularly in low- and middle-income countries. The assay detects HCV RNA reliably, faster than existing methods, and can be used at the point of care, reducing the need for centralized laboratories.

SourceInstitut Pasteur·JournalGut·DateApr 10, 2018